At the time of writing, Johnson & Johnson [JNJ] stock is trading at $145.74, up 0.67%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The JNJ shares have lost -2.05% over the last week, with a monthly amount drifted -6.70%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Johnson & Johnson [NYSE: JNJ] stock has seen the most recent analyst activity on April 18, 2024, when HSBC Securities upgraded its rating to a Buy but kept the price target unchanged to $170 for it. Previously, Wells Fargo downgraded its rating to Equal Weight on December 13, 2023, and dropped its price target to $163. On December 01, 2023, upgrade upgraded it’s rating to Buy and revised its price target to $180 on the stock. RBC Capital Mkts started tracking the stock assigning a Outperform rating and suggested a price target of $178 on October 05, 2023. HSBC Securities initiated its recommendation with a Hold and recommended $175 as its price target on September 06, 2023. In a note dated March 29, 2023, UBS initiated an Neutral rating and provided a target price of $164 on this stock.
For the past year, the stock price of Johnson & Johnson fluctuated between $143.39 and $175.97. Currently, Wall Street analysts expect the stock to reach $177.57 within the next 12 months. Johnson & Johnson [NYSE: JNJ] shares were valued at $145.74 at the most recent close of the market. An investor can expect a potential return of 21.84% based on the average JNJ price forecast.
Analyzing the JNJ fundamentals
According to Johnson & Johnson [NYSE:JNJ], the company’s sales were 89.66B for trailing twelve months, which represents an -13.55% plunge. Gross Profit Margin for this corporation currently stands at 0.68% with Operating Profit Margin at 0.26%, Pretax Profit Margin comes in at 0.17%, and Net Profit Margin reading is 0.38%. To continue investigating profitability, this company’s Return on Assets is posted at 0.21, Equity is 0.49 and Total Capital is 0.2. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.43.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 143.98 points at the first support level, and at 142.22 for the second support level. However, for the 1st resistance point, the stock is sitting at 146.65, and for the 2nd resistance point, it is at 147.56.
Ratios To Look Out For
It is important to note that Johnson & Johnson [NYSE:JNJ] has a current ratio of 1.16. Also, the Quick Ratio is 0.91, while the Cash Ratio stands at 0.47. Considering the valuation of this stock, the price to sales ratio is 3.92, the price to book ratio is 5.10 and price to earnings (TTM) ratio is 18.67.
Transactions by insiders
Recent insider trading involved Broadhurst Vanessa, EVP, Global Corp Affairs, that happened on Mar 13 ’24 when 8891.0 shares were sold. 10% Owner, JOHNSON & JOHNSON completed a deal on Feb 16 ’24 to sell 3725.0 shares. Meanwhile, EVP, WW Chair, Pharmaceuticals Taubert Jennifer L sold 59397.0 shares on Feb 09 ’24.
